193 related articles for article (PubMed ID: 28822915)
1. Immunomodulatory effects of M2000 (β-D-Mannuronic acid) on TNF-α, IL-17 and FOXP3 gene expression in patients with inflammatory bowel disease.
Mohammed HA; Saboor-Yaraghi AA; Vahedi H; Yekaninejad MS; Panahi G; Hemmasi G; Lakzaei M; Mirshafiey A
Int Immunopharmacol; 2017 Oct; 51():107-113. PubMed ID: 28822915
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapeutic Effects of β-D Mannuronic Acid on IL-4, GATA3, IL-17 and RORC Gene Expression in the PBMC of Patients with Inflammatory Bowel Diseases.
Alhassan Mohammed H; Saboor-Yaraghi AA; Vahedi H; Panahi G; Hemmasi G; Yekaninejad MS; Mirshafiey A
Iran J Allergy Asthma Immunol; 2018 Aug; 17(4):308-317. PubMed ID: 30537794
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of β-D-Mannuronic Acid [M2000] on the Pro-Apoptotic Process and Inflammatory-Related Molecules NFκB, IL-8 and Cd49d using Healthy Donor PBMC.
Khalatbari A; Mahdavi M; Jafarnezhad F; Afraei S; Zavareh FT; Aghazadeh Z; Ghaderi A; Mirshafiey A
Curr Drug Discov Technol; 2020; 17(2):225-232. PubMed ID: 30417790
[TBL] [Abstract][Full Text] [Related]
4. The Inhibitory Role of M2000 (β-D-Mannuronic Acid) on Expression of Toll-like Receptor 2 and 4 in HT29 Cell Line.
Sharifi L; Moshiri M; Dallal MMS; Asgardoon MH; Nourizadeh M; Bokaie S; Mirshafiey A
Recent Pat Inflamm Allergy Drug Discov; 2019; 13(1):57-65. PubMed ID: 30539708
[TBL] [Abstract][Full Text] [Related]
5. An in vitro assessment for evaluating the efficiency of β-d-mannuronic acid (M2000) in myelodysplastic syndrome.
Bakhtiari T; Ghaderi A; Safaee Nodehi SR; Aghazadeh Z; Tofighi Zavareh F; Jafarnezhad-Ansariha F; Barati A; Mirshafiey A
J Cell Physiol; 2019 Aug; 234(8):12971-12977. PubMed ID: 30537258
[TBL] [Abstract][Full Text] [Related]
6. Evaluating Mannuronic Acid Effect on Gene Expression Profile of Inflammatory Mediators in Rheumatoid Arthritis Patients.
Omidian S; Aghazadeh Z; Ahmadzadeh A; Aslani M; Hosseini M; Abbasi S; Mirshafiey A
Iran J Allergy Asthma Immunol; 2022 Feb; 21(1):44-54. PubMed ID: 35524377
[TBL] [Abstract][Full Text] [Related]
7. The role of β-d-mannuronic acid, as a new non-steroidal anti-inflammatory drug on expression of miR-146a, IRAK1, TRAF6, NF-κB and pro-inflammatory cytokines following a clinical trial in rheumatoid arthritis patients.
Mortazavi-Jahromi SS; Ahmadzadeh A; Rezaieyazdi Z; Aslani M; Omidian S; Mirshafiey A
Immunopharmacol Immunotoxicol; 2020 Jun; 42(3):228-236. PubMed ID: 32223462
[No Abstract] [Full Text] [Related]
8. IL-23/IL-17A axis correlates with the nitric oxide pathway in inflammatory bowel disease: immunomodulatory effect of retinoic acid.
Rafa H; Saoula H; Belkhelfa M; Medjeber O; Soufli I; Toumi R; de Launoit Y; Moralès O; Nakmouche M; Delhem N; Touil-Boukoffa C
J Interferon Cytokine Res; 2013 Jul; 33(7):355-68. PubMed ID: 23472658
[TBL] [Abstract][Full Text] [Related]
9. β-D-mannuronic Acid (M2000) and Inflammatory Cytokines in COVID-19; An In vitro Study.
Robat-Jazi B; Ghorban K; Gholami M; Samizadeh E; Aghazadeh Z; Shahrbaf MA; Dadmanesh M; Hosseini Rouzbahani N; Mirshafiey A
Iran J Allergy Asthma Immunol; 2022 Dec; 21(6):677-686. PubMed ID: 36640059
[TBL] [Abstract][Full Text] [Related]
10. Immunoregulatory properties of IL-13 in patients with inflammatory bowel disease; comparison with IL-4 and IL-10.
Kucharzik T; Lügering N; Weigelt H; Adolf M; Domschke W; Stoll R
Clin Exp Immunol; 1996 Jun; 104(3):483-90. PubMed ID: 9099934
[TBL] [Abstract][Full Text] [Related]
11. Targeting of circulating Th17 cells by β-D-mannuronic acid (M2000) as a novel medication in patients with rheumatoid arthritis.
Ahmadi H; Mahmoudi M; Gharibdoost F; Vojdanian M; Jamshidi AR; Fattahi MJ; Aghazadeh Z; Barati A; Mirshafiey A
Inflammopharmacology; 2018 Feb; 26(1):57-65. PubMed ID: 29063487
[TBL] [Abstract][Full Text] [Related]
12. The Oral Administration Effect of Drug Mannuronic Acid (M2000) on Gene Expression of Matrix and Tissue Inhibitor of Metalloproteinases in Rheumatoid Arthritis Patients.
Gaafar NAG; Aslani M; Aghazadeh Z; Razavi A; Mirshafiey A
Curr Drug Discov Technol; 2020; 17(5):704-710. PubMed ID: 31250758
[TBL] [Abstract][Full Text] [Related]
13. Foxp3+ regulatory T cells, Th17 effector cells, and cytokine environment in inflammatory bowel disease.
Eastaff-Leung N; Mabarrack N; Barbour A; Cummins A; Barry S
J Clin Immunol; 2010 Jan; 30(1):80-9. PubMed ID: 19936899
[TBL] [Abstract][Full Text] [Related]
14. Effects of β-d-mannuronic acid, as a novel non-steroidal anti-inflammatory medication within immunosuppressive properties, on
Barati A; Jamshidi AR; Ahmadi H; Aghazadeh Z; Mirshafiey A
Drug Des Devel Ther; 2017; 11():1027-1033. PubMed ID: 28408801
[TBL] [Abstract][Full Text] [Related]
15. Anti-tumor effect of M2000 (β-d-mannuronic acid) on the expression of inflammatory molecules in the prostate cancer cell.
Mohsenzadegan M; Moghbeli F; Mirshafiey A; Farajollahi MM
Immunopharmacol Immunotoxicol; 2021 Aug; 43(4):419-430. PubMed ID: 34057866
[No Abstract] [Full Text] [Related]
16. Effect of β-D-Mannuronic Acid (M2000) on Oxidative Stress Enzymes' Gene Using Healthy Donor Peripheral Blood Mononuclear Cells for Evaluating the Anti-Aging Property.
Taeb M; Jafarzadeh A; Mortazavi-Jahromi SS; Zainodini N; Mirzaei MR; Jafarnezhad-Ansariha F; Aghazadeh Z; Mirshafiey A
Curr Drug Discov Technol; 2019; 16(3):265-271. PubMed ID: 29766814
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological effects of TAK-828F: an orally available RORγt inverse agonist, in mouse colitis model and human blood cells of inflammatory bowel disease.
Igaki K; Nakamura Y; Tanaka M; Mizuno S; Yoshimatsu Y; Komoike Y; Uga K; Shibata A; Imaichi H; Takayuki S; Ishimura Y; Yamasaki M; Kanai T; Tsukimi Y; Tsuchimori N
Inflamm Res; 2019 Jun; 68(6):493-509. PubMed ID: 30972425
[TBL] [Abstract][Full Text] [Related]
18. M2000 (β-D-Mannuronic Acid) as a Novel Antagonist for Blocking the TLR2 and TLR4 Downstream Signalling Pathway.
Aletaha S; Haddad L; Roozbehkia M; Bigdeli R; Asgary V; Mahmoudi M; Mirshafiey A
Scand J Immunol; 2017 Feb; 85(2):122-129. PubMed ID: 27943385
[TBL] [Abstract][Full Text] [Related]
19. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
Pedersen G
Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
[TBL] [Abstract][Full Text] [Related]
20. Interaction among vitamin D(3) analogue KH 1060, TNF-alpha, and vitamin D receptor protein in peripheral blood mononuclear cells of inflammatory bowel disease patients.
Stio M; Martinesi M; Bruni S; Treves C; d'Albasio G; Bagnoli S; Bonanomi AG
Int Immunopharmacol; 2006 Jul; 6(7):1083-92. PubMed ID: 16714211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
